CSCC treatment: Surgery or radiotherapy

touchMDT for touchIMMUNOLOGY

Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.

The multidisciplinary team

• Radiation oncologist: Dr Agata Rembielak, UK
• Head and neck surgeon: Prof. Francesco Bussu, Italy

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management